In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia - a yeast infection in the bloodstream - had more positive outcomes as they relate to mortality when infectious disease consultation (IDC) occurred during their hospital stay.
“Candidemia has mortality rates as high as 50 percent, and we wanted to better understand the impact that infectious disease consultation in hospitalized patients can have, specifically as it relates to survival rates and guideline adherence,” said Rachael Lee, MD, lead author of the study and assistant professor in UAB’s Division of Infectious Diseases.
The study, published in Clinical Infectious Diseases, looked at outcomes of 145 patients hospitalized with candidemia at UAB Hospital from Jan. 1, 2015, to July 31, 2016. Some 111 patients received IDC, while the other 39 did not.
Findings determined that 30-day, 60-day and overall inpatient mortality rates were significantly lower in IDC patients, and there was an increased adherence to clinical practice guidelines. In addition, patients with IDC were 66 percent less likely to die within 30 days compared to those without IDC. Data also indicated that IDC may benefit even critically ill patients with high APACHE II scores, which determines ICU mortality.
Furthermore, early IDC can help patients get on an antifungal therapy more quickly, which has been shown to lead to better outcomes.
“It has been well-established that ID consultation is associated with improved survival in Staphylococcus aureus bloodstream infections, and the findings in this study are similar and reassuring,” Lee said. “Here at UAB, we have instituted the practice of automatic IDC for patients with candidemia, and while we know that future studies are needed, we believe that patients with candidemia can only benefit from receiving IDC, especially early on in their hospitalization.”
Source: University of Alabama at Birmingham
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.